INSIGHTS ON CLINICAL TRIAL PARTNERING

• Optimizing Clinical Supply Management With A One-Team Approach

  See how NewAmsterdam Pharma managed 11 global studies across 51 countries and 835 sites for 12,000+ patients without overwhelming their internal team.

• Central eSource: Leveraging Site Technology

  In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.

• A Sponsor's Guide To Evaluating CRO Data Governance

  Evaluate CRO data governance with a risk-based framework that strengthens data quality, traceability, compliance, and regulatory readiness.

• Why Early Medical Assessment Matters In Clinical Trials

  Early medical assessment reduces risk, improves patient selection, and avoids trial delays. Learn how starting early boosts compliance, speeds timelines, and protects participants and results.

• The Hidden Financial Causes Of Patient Transportation Breakdowns In Clinical Trials

  6/15/2026

  Transport issues in trials often stem from fragmented financial workflows. Integrating payments with travel coordination reduces delays and supports reliable visits.

• Ergomed's Solutions To The Challenges of Oncology Trials

  4/15/2025

  Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

• From Frustration To Organization: An SSO Platform For Trial Sites

  5/2/2025

  To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.

• Prospecting Biospecimen Collections To Power Precision Medicine

  10/15/2025

  High-quality biospecimens are the foundation of precision medicine success. Learn the five crucial steps—from planning to compliance—for a prospective biospecimen collection that is scientifically robust and accelerates your research.

• Accelerating Recruitment In A Challenging Phase III Rare Disease Trial

  8/18/2026

  Recruiting for rare acute diseases is challenging. Discover how this organization used rapid site activation and investigator engagement to speed enrollment in a Phase III Anti-GBM trial.